Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | 120,675 | reported | 22 Feb 2020 | tx 55+1,087,797−245,901 |
| Mirati Therapeutics, Inc. | 102,312 | reported | 09 Aug 2023 | tx 6+243,579−4,647 |
| PMV Pharmaceuticals, Inc. | 33,500 | reported | 05 Jun 2025 | tx 5+122,500−35,833 |
| MBX Biosciences, Inc. | 32,000 | reported | 20 Jan 2026 | tx 1+32,000 |
| Surface Oncology, Inc. | 24,000 | reported | 08 Jun 2022 | tx 4+65,800 |
| ARENA PHARMACEUTICALS INC | 21,462 | reported | 11 Mar 2022 | tx 15+233,072−240,214 |
| Sionna Therapeutics, Inc. | 19,959 | reported | 12 Jun 2025 | tx 1+19,959 |
| Spyre Therapeutics, Inc. | 8,026 | reported | 27 May 2026 | tx 4+94,349 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 8,026 | 0.00 USD | deriv |
| 20 Jan 2026 | GRANT_AWARD | MBX Biosciences, Inc. | 32,000 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Sionna Therapeutics, Inc. | 19,959 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 33,500 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 67,500 | 0.00 USD | deriv |
| 14 May 2024 | GRANT_AWARD | Spyre Therapeutics, Inc. | 11,323 | 0.00 USD | deriv |
| 22 Nov 2023 | GRANT_AWARD | Spyre Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 09 Aug 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 22,297 | 37.00 USD | |
| 08 Jun 2023 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 21,500 | 0.00 USD | deriv |
| 02 Jun 2023 | SALE | Mirati Therapeutics, Inc. | 4,647 | 37.06 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 26,864 | 0.00 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 45,456 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Surface Oncology, Inc. | 24,000 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 19,500 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Mirati Therapeutics, Inc. | 57,798 | 0.00 USD | |
| 01 Jun 2022 | GRANT_AWARD | Mirati Therapeutics, Inc. | 91,164 | 0.00 USD | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 9,086 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 21,462 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 6,660 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 38,850 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 15,200 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 132,000 | — | deriv |
| 03 Jan 2022 | GRANT_AWARD | ARENA PHARMACEUTICALS INC | 21,462 | 0.00 USD | |
| 08 Jun 2021 | GRANT_AWARD | Surface Oncology, Inc. | 17,700 | 0.00 USD | deriv |